Idiopathic pulmonary fibrosis
RecruitingPhase IIb Study of AZD8965 versus Placebo in Adults with Idiopathic Pulmonary Fibrosis
- Disease:Idiopathic pulmonary fibrosis
- Substances:–
Italy- Participants:18–64 years · 65+ years
- Sponsor:AstraZeneca AB
Rare diseases
Investigational molecules
Locations
Back to Italy23 clinical trials in Forli', Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)
Italy
Italy
Italy
Italy
Italy
Italy
Italy
Italy
Italy
Italy
Italy
ItalyThe busiest research cities in the country
What the registry says about research in the country
Comprehensive clinical trials focusing on idiopathic pulmonary fibrosis (IPF) and related conditions, evaluating innovative treatments to improve lung function and patient outcomes.
Multiple studies testing inhaled and oral medications for treating various forms of pulmonary fibrosis.
Investigation of new treatments for pulmonary sarcoidosis, including trials examining innovative therapies aimed at reducing corticosteroid dependence.
Research focusing on both pulmonary and systemic manifestations of sarcoidosis.
Studies addressing cardiac conditions, including specialized trials for amyloid cardiomyopathy and atrial fibrillation management.
Innovative approaches to treating complex cardiovascular disorders and their complications.
Tell us about your condition – we search every trial in Europe and connect you with the right site.